2022 annual financial data
LENZ Therapeutics 2022 Net margin
Direct answer
Net margin was -72.07%.
Operating income was -10,483,000 USD and net income was -10,811,000 USD.
Operating cash flow was -87,980,000 USD.
Get free LENZ Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 15,000,000 USD
- Operating income
- -10,483,000 USD
- Net income
- -10,811,000 USD
- Operating cash flow
- -87,980,000 USD